Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & EquivalentsCommon EquityCurrent AssetsLiabilities and Shareholders EquityNon-Current AssetsPayablesPrepaid AssetsRetained EarningsShareholder's EquityShares OutstandingTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Tenax Therapeutics (TENX) Total Liabilities (2016 - 2026)

Tenax Therapeutics' Total Liabilities history spans 7 years, with the latest figure at $1.0 million for Q4 2017.

  • On a quarterly basis, Total Liabilities fell 83.73% to $1.0 million in Q4 2017 year-over-year; TTM through Dec 2017 was $1.0 million, a 83.73% decrease, with the full-year FY2017 number at $1.0 million, down 83.73% from a year prior.
  • Total Liabilities hit $1.0 million in Q4 2017 for Tenax Therapeutics, up from $838552.0 in the prior quarter.
  • Over the last five years, Total Liabilities for TENX hit a ceiling of $13.2 million in Q2 2016 and a floor of -$82.9 million in Q2 2014.
  • Historically, Total Liabilities has averaged -$7.5 million across 5 years, with a median of $4.8 million in 2013.
  • Biggest five-year swings in Total Liabilities: plummeted 1770.92% in 2014 and later grew 15.0% in 2015.
  • Tracing TENX's Total Liabilities over 5 years: stood at $5.0 million in 2013, then plummeted by 1770.92% to -$82.9 million in 2014, then skyrocketed by 115.16% to $12.6 million in 2015, then crashed by 50.66% to $6.2 million in 2016, then tumbled by 83.73% to $1.0 million in 2017.
  • Business Quant data shows Total Liabilities for TENX at $1.0 million in Q4 2017, $838552.0 in Q3 2017, and $2.2 million in Q2 2017.